Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

“It provides patients with additional choices when we think about treating fatty liver disease.” MASH is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD ...

This integrated trio of care wasn’t always available to patients with liver disease, says Courtney Sherman, MD, hepatologist and associate professor at UC San Francisco. HALT founders Courtney Sherman ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

But a 72-week regimen of semaglutide seemed to turn the disease around. Patients on the drug saw liver scarring improve ... like “your legs swelling up so much you can’t tie your shoes ...

Discover a study, involving over 13,000 patients with MASLD, that compared mortality rates and causes of death. Learn more.

Cardiovascular disease (CVD) is the most common cause of death in NAFLD patients. Liver biopsy and noninvasive markers should be used to stage and grade nonalcoholic steatohepatitis (NASH ...

This integrated trio of care wasn't always available to patients with liver disease, says Courtney Sherman, MD, hepatologist and associate professor at UC San Francisco. "In medical school ...